A R T I C L E S
Mucsi et al.
Chart 1. Different Conformations of N-Propargylmorpholine
Scheme 1. Rearrangements of N-Propargylmorpholine N-Oxide
(1)
N-Oxide (1)
a dramatic rate acceleration when an electron-pair acceptor
(EPA) ionophore (e.g., LiClO4 or NaClO4) is added to the
reaction mixture.23,29,30 These results were explained by the
enhanced polarity of the TSs, stabilized less effectively by HBD
solvents and EPAs, as compared with that in the reactants.
This unexpected solvent effect was a challenge to develop
theoretical methods for prediction of the effect of the reaction
medium. The Meisenheimer rearrangement of N-oxides is
additionally of biological importance. In vivo degradation of
the excellent irreversible monoamine oxidase (MAO) inhibi-
tors31,32 (e.g., MAO-A: Clorgyline, Abbott-21.855; MAO-B:
Selegiline, Pargyline), essentially tertiary amines with N-
propargyl and N-methyl substituents (for individual structures,
see Scheme S1 in the Supporting Information), starts with a
Meisenheimer rearrangement of the corresponding N-oxides.15
Furthermore, it has recently been discovered33 that Selegiline-
N-oxide is a very strong neuroprotective agent. This discovery
is suggestive of the promise of development of a potential new
drug.
1.3. Scope. In our present work, we started from the well-
established mechanism of the rearrangement of 1 that we
proposed earlier.16,17 To reveal the controlling role of the reaction
medium, we carried out the reaction not only in the previously
investigated HBD solvents (MeOH, EtOH, i-PrOH, and t-
BuOH), but also in other HBD solvents [H2O, CF3CH2OH,
(CF3)2CHOH, CHCl3, CHBr3, CH2Cl2, and MeNO2], in non-
HBD solvents (Me2SO, MeCN, Me2CO, pyridine, and dioxane),
in the presence of electron-pair acceptors (EPAs such as Li+,
Na+, nitro derivatives of benzene, BF3:OEt2 and H+ interacting
with the nonbonding electron pair of the N-oxide oxygen), and
in deuterated solvents (D2O, CD3OD, C2D5OD, CDCl3, CDBr3,
and CD2Cl2).
evidence that an explicit consideration of solvent molecules is
essential for an acceptable description of chemical processes.
To study the solvent effect, we have chosen the pericyclic
Meisenheimer rearrangement of N-propargylmorpholine N-oxide
1 in different solvents (Scheme 1). In earlier work,15-17 we
demonstrated that both the rate and the product distribution of
this pericyclic reaction, which proceeds through a cyclic-
activated complex (transition state: TS 2), are affected by the
nature of the solvent. In aprotic solvents (e.g., in diethyl ether)
a trisubstituted hydroxylamine, N-(propadienyloxy)morpholine
(3; “O-allenylhydroxylamine” in ref 16) was formed by N-C
bond cleavage as a result of the Meisenheimer rearrange-
ment.18,19 In protic solvents (e.g., in C1-C4 alcohols), however,
the rate of the Meisenheimer rearrangement was markedly
decreased, and in a competitive rearrangement involving
N-O cleavage 3-(3-oxapentane-1,5-diyl) aminoacrylaldehyde
(4; “enamino aldehyde” in ref 16) was formed and became the
main component. In C1-C4 alcohols, kinetic measurements were
performed to determine the rate constants and the activation
parameters for both rearrangements.16 Preliminary theoretical
calculations were also carried out to reveal the mechanisms of
the competing reaction pathways.17
The fact that the rearrangements of N-oxide 1,18,19 involving
a pericyclic rate-determining step, exhibit a significant solvent
dependence was unexpected. Most pericyclic reactions that
proceed through an isopolar TS (differing in charge separation
very little, if at all, from the initial reactant) are not appreciably
affected by changes in the substituent or the reaction medium.20-23
In a few cases, for example, in hetero Diels-Alder reactions,
the pericyclic step proceeds markedly faster in hydrogen-bond
donor (HBD) solvents than in non-HBD ones,24-28 and there is
In the models of solvent effects, the solvents and media are
divided into two groups. Type 1 media are non-HBD (aprotic)
solvents: Me2SO, MeCN, Me2CO, pyridine, dioxane, and
vacuum. For appropriate modeling, we divided the type 2
solvents into two subgroups: weak HBD solvents such as
CHCl3,34-37 CHBr3, CH2Cl2, and MeNO2 (prominently weak)
belong to type 2A, whereas strong HBD solvents such as H2O,
MeOH, EtOH, CF3CH2OH, i-PrOH, (CF3)2CHOH, and t-BuOH
belong to type 2B.38-40
(8) Jones-Hertzog, D. K.; Jorgensen, W. L. J. Am. Chem. Soc. 1995, 117, 9077-
9078.
(9) Cossi, M.; Barone, V. J. Chem. Phys. 2000, 112, 2427-2435.
(10) Cossi, M.; Barone, V. J. Chem. Phys. 2001, 115, 4708-4717.
(11) Sicinska, D.; Paneth, P.; Truhlar, D. G. J. Phys. Chem. B 2002, 106, 2708-
2713.
(12) Lee, M. R.; Tsai, J.; Baker, D.; Kollman, P. A. J. Mol. Biol. 2001, 313,
417-430.
(13) Roux, B.; Simonson, T. Biophys. Chem. 1999, 78, 1-20.
(14) Importa, R.; Scalmi, G.; Barone, V. Chem. Phys. Lett. 2001, 336, 349-
356.
(15) Szabo´, A.; Hermecz, I. J. Org. Chem. 2001, 66, 7219-7222.
(16) Szabo´, A.; Galambos-Farago´, AÄ .; Mucsi, Z.; Tima´ri, G.; Vasva´ri-Debreczy,
L.; Hermecz, I. Eur. J. Org. Chem. 2004, 687-694.
(17) Mucsi, Z.; Szabo´, A.; Hermecz, I. J. Mol. Struct. (THEOCHEM) 2004,
666-667, 547-556.
(18) Johnstone, R. A. W. Mech. Mol. Migr. 1969, 2, 249-266.
(19) Scho¨llkopf, U.; Patsch, M.; Scha¨fer, H. Tetrahedron Lett. 1964, 36, 2515-
2520.
(20) Dewar, M. J. S.; Pyron, R. S. J. Am. Chem. Soc. 1970, 92, 3098-3103.
(21) Harkness, J. B.; Kistiakowsky, G. B.; Mears, W. H. J. Chem. Phys. 1937,
5, 682-694.
(22) Kaufmann, H.; Wassermann, J. J. Chem. Soc. 1939, 870-871.
(23) Reichardt, C. SolVents and SolVents Effect in Organic Chemistry; Wiley-
VCH: Weinheim, Germany, 2003; Chapter 5, pp 148-328.
(24) Rideout, D. C.; Breslow, R. J. Am. Chem. Soc. 1980, 102, 7816-7817.
(25) Breslow, R. Acc. Chem. Res. 1991, 24, 159-164.
(26) Breslow, R. Green Chem. 1998, 225-233.
(27) Jorgensen, W. L.; Blake, J. F.; Lim, D.; Severance, D. L. J. Chem. Soc.,
Faraday Trans. 1994, 90, 1727-1732.
(28) Kumar, A. Chem. ReV. 2001, 101, 1-19.
(29) Sankararaman, S.; Nesakumar, J. E. Eur. J Org. Chem. 2000, 2003-2011.
(30) Waldmann, H. Angew. Chem. 1991, 103, 1335-1337.
(31) Abeles, R. H.; Maycock, A. L. Acc. Chem. Res. 1976, 9, 313-319.
(32) Gaa´l, J.; Hermecz, I. In Inhibitors of Monoamine Oxidase B; Szele´nyi, I.,
Ed.; Birkha¨user: Basel, 1999; pp 75-108.
(33) Magyar, K.; Pa´lfi, M.; Ta´bi, T.; Kala´sz, H.; Szende, B.; Szo¨ko¨, EÄ . Curr.
Med. Chem. 2004, 11, 2017-2031.
(34) Douglas, C.; McHale, J. L. J. Phys. Chem. A 1997, 101, 3070-3077.
(35) Sauer J.; Prahl, H. Chem. Ber. 1969, 102, 1917-1927.
(36) Greenwald, R.; Chaykovsky, M.; Corey, E. J. J. Org. Chem. 1963, 28,
1128-1129.
(37) Domingo, L. R.; Andre´s, J. J. Org. Chem. 2003, 68, 8662-8668.
9
7616 J. AM. CHEM. SOC. VOL. 127, NO. 20, 2005